|
Written by a team of leading authorities in pathogenesis, diagnostic techniques, and clinical management strategies in myelodysplastic syndrome (MDS), this text provides a concise, easy-to-follow review of the advances in the science, classification, diagnosis, and management of the condition.
An ideal source for hematologists, oncologists, and cancer researchers, this Second Edition features:
a new eight-page color insert
200 color and black-and-white illustrations
reworked content organized into three sections: MDS epidemiology and biology; diagnosis, classification, and prognosis; and MDS therapy
thoroughly updated chapters reflecting a shift from the topical focus as dictated by the evolution of the field
New topics in Myelodysplastic Syndrome include:
del(5q) and 5q-syndrome, CMML, and MDS-MPD overlap syndrome
the reborn DNA methyltransferase inhibiting nucleoside analogs
the diagnosis of chronic myelomonocytic leukemia and other MDS cases with myeloproliferative features
the role of mitochondria and the potential importance of iron overload in MDS
global genomics approaches, such as cDNA expression arrays, array-based comparative genomic hybridization, and single nucleotide polymorphism array
the role of abnormal mitochondrial ferritin accumulation and other mitochondrial metabolic anomalies in MD
other disease-associated alterations, such as abnormalities of B lymphocyte populations in MD
three recently approved drugs: azacitidine, lenalidomide, and decitabine
|
